Dr Frances Johnson has a background as a cardiologist. She is a well-published clinician, researcher and educator. Dr Michael Schultz is Associate Professor with experience from radiology, radiation oncology, pediatrics and chemistry. In 2008, when they both worked at University of Maryland, they started Viewpoint Molecular Targeting. A radiopharmaceutical company with a theragnostic portfolio using Alpha emitting isotopes.
Please join us in this episode of Theragnostic Talks.